Try GOLD - Free
Japan's Suzuki Trims India Sales Target, Scales Back EV Launches
Mint Bangalore
|February 21, 2025
Japanese carmaker Suzuki Motor has trimmed its sales target in India, its "most important market", and scaled back its line-up of electric car launches, even as it plans to expand global sales by a third to 4.2 million vehicles by fiscal year 2030.
Suzuki expects to sell about 2.5 million cars in India by March 2031, down from an October 2023 target of 3 million, and will launch just four EVs in the country instead of six planned, the company said on Thursday.
The sales cut in India, Suzuki's biggest market by revenue and volumes, comes as local unit Maruti Suzuki has been losing ground to new, feature-rich cars and SUVs from rivals Tata Motors and Mahindra & Mahindra.
This story is from the February 21, 2025 edition of Mint Bangalore.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Bangalore
Mint Bangalore
When a compact smartphone can be a flagship
A premium and compact handset with flagship build and comforts
2 mins
June 24, 2026
Mint Bangalore
Noel Tata to end Trent stint leaving behind retail empire
Tata will retire as Trent chairman, ending a nearly three-decade association with the retailer
2 mins
June 24, 2026
Mint Bangalore
JSW bets on in-house e-bus tech to power tender bids
JSW is building an indigenous e-bus platform, vehicle control unit and battery pack design
2 mins
June 24, 2026
Mint Bangalore
Let us not confuse seats and seat share with parliamentary power
Delimitation would shift the relative political power of Indian states in a far more complex way
3 mins
June 24, 2026
Mint Bangalore
Bars crawl, eateries buzz as football fest unfolds
Fifa World Cup’s post-midnight timings mean it’s not party time for India’s high-street bars.
2 mins
June 24, 2026
Mint Bangalore
Honasa to acquire 58% stake in Fluence Pharma
Beauty and personal care consumer Ltd will acquire 58% stake in Fluence Pharma, a science-backed nutraceuticals company, at an enterprise value of ₹135 crore.
1 min
June 24, 2026
Mint Bangalore
Growth needs new reforms, not stimulus: CII’s Mukundan
Current global disruptions should be viewed as an opportunity to push reforms, he says
2 mins
June 24, 2026
Mint Bangalore
Fairfax buys nearly $1 bn in Indian bonds
Fairfax bought Indian government debt worth nearly $1 billion last Friday, according to five sources, in a rare purchase through the local unit of the Canadian investment holding company.
1 min
June 24, 2026
Mint Bangalore
Tata Motors targets bigger slice of PV and CV markets
Tata Motors Passenger Vehicle Ltd and Tata Motors Ltd have set ambitious market share goals, with the passenger vehicle business aiming for a 20% share by 2030-31 and the commercial vehicle unit targeting 40% by 2027-28.
2 mins
June 24, 2026
Mint Bangalore
The competition regulator has lost a power it never had
The Supreme Court recently set aside a penalty of ₹202 crore imposed on Amazon by the Competition Commission of India (CCI).
3 mins
June 24, 2026
Listen
Translate
Change font size